The European Medicines Group (EMG) represents 20 continental European headquartered research-based pharmaceutical companies which together are significant investors and employers in the UK, and make a major contribution to the NHS and its ability to deliver better patient outcomes across a broad range of conditions.
EMG member companies:
- Have researched and developed some of the most innovative medicines currently available to improve the health and well-being of UK citizens
- Invest upwards of £1 bn per year in research and development in the UK. A significant proportion in clinical studies conducted by NHS Trusts, not only enabling the NHS to be a leader in clinical research but providing NHS Trusts with an important source of direct income
- Contributed £1.85 bn to the UK economy in 2015 alone with almost two thirds of this (£1.14 bn) by direct Gross Value Added (GVA)
- Collectively support 37,650 jobs in the UK. This is comprised of 8,550 directly employed people; 18,300 indirect jobs in companies in the Life Sciences supply chain and 10,800 jobs through induced effects.
- Operate from over 40 sites across all regions of the UK covering manufacturing, research, packaging and commercial operations.
- Are proud to reflect the diversity of UK society in the make-up of our organisations, providing good quality jobs, working conditions and opportunities for all genders and ethnicities.